These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 31469338)
21. Resistance of enterococci to ampicillin and glycopeptide antibiotics in Italy. The Italian Surveillance Group for Antimicrobial Resistance. Fontana R; Ligozzi M; Mazzariol A; Veneri G; Cornaglia G Clin Infect Dis; 1998 Aug; 27 Suppl 1():S84-6. PubMed ID: 9710675 [TBL] [Abstract][Full Text] [Related]
22. Successful treatment of persistent bacteremia due to vancomycin-resistant, ampicillin-resistant Enterococcus faecium. Mekonen ET; Noskin GA; Hacek DM; Peterson LR Microb Drug Resist; 1995; 1(3):249-53. PubMed ID: 9158783 [TBL] [Abstract][Full Text] [Related]
23. Antimicrobial resistance profile of Enterococcus species isolated from intestinal tracts of hospitalized patients in Jimma, Ethiopia. Abamecha A; Wondafrash B; Abdissa A BMC Res Notes; 2015 Jun; 8():213. PubMed ID: 26036911 [TBL] [Abstract][Full Text] [Related]
24. New colony multiplex PCR assays for the detection and discrimination of vancomycin-resistant enterococcal species. Nomura T; Hashimoto Y; Kurushima J; Hirakawa H; Tanimoto K; Zheng B; Ruan G; Xue F; Liu J; Hisatsune J; Sugai M; Tomita H J Microbiol Methods; 2018 Feb; 145():69-72. PubMed ID: 29309802 [TBL] [Abstract][Full Text] [Related]
26. First outbreak of linezolid-resistant vancomycin-resistant Enterococcus faecium in an Irish hospital, February to September 2014. O'Driscoll C; Murphy V; Doyle O; Wrenn C; Flynn A; O'Flaherty N; Fenelon LE; Schaffer K; FitzGerald SF J Hosp Infect; 2015 Dec; 91(4):367-70. PubMed ID: 26520594 [TBL] [Abstract][Full Text] [Related]
27. Vancomycin resistance emerging in a clonal outbreak caused by ampicillin-resistant Enterococcus faecium. Harthug S; Digranes A; Hope O; Kristiansen BE; Allum AG; Langeland N Clin Microbiol Infect; 2000 Jan; 6(1):19-28. PubMed ID: 11168032 [TBL] [Abstract][Full Text] [Related]
28. Molecular Epidemiology of Vancomycin-Resistant Enterococcus faecalis and Enterococcus faecium Isolated from Clinical Specimens in the Northwest of Iran. Jahansepas A; Ahangarzadeh Rezaee M; Hasani A; Sharifi Y; Rahnamaye Farzami M; Dolatyar A; Aghazadeh M Microb Drug Resist; 2018 Oct; 24(8):1165-1173. PubMed ID: 29708837 [TBL] [Abstract][Full Text] [Related]
29. High-Level Fosfomycin Resistance in Vancomycin-Resistant Enterococcus faecium. Guo Y; Tomich AD; McElheny CL; Cooper VS; Tait-Kamradt A; Wang M; Hu F; Rice LB; Sluis-Cremer N; Doi Y Emerg Infect Dis; 2017 Nov; 23(11):1902-1904. PubMed ID: 29048285 [TBL] [Abstract][Full Text] [Related]
30. The importance of adjusting for enterococcus species when assessing the burden of vancomycin resistance: a cohort study including over 1000 cases of enterococcal bloodstream infections. Kramer TS; Remschmidt C; Werner S; Behnke M; Schwab F; Werner G; Gastmeier P; Leistner R Antimicrob Resist Infect Control; 2018; 7():133. PubMed ID: 30459945 [TBL] [Abstract][Full Text] [Related]
32. In vitro activity of RPR 106972 alone and in combination with vancomycin, ampicillin, and gentamicin against multidrug-resistant enterococci. Messick CR; Woodward J; Pendland SL Diagn Microbiol Infect Dis; 1998 Oct; 32(2):95-9. PubMed ID: 9823531 [TBL] [Abstract][Full Text] [Related]
33. First report of ampicillin and glycopeptide resistant Enterococcus faecium VanA bacteraemia in Greece. Kouppari G; Papadaki H; Arida C; Sakellariou J; Legakis NJ; Papaparaskevas J Int J Antimicrob Agents; 2000 Nov; 16(3):254-6. PubMed ID: 11185546 [No Abstract] [Full Text] [Related]
34. 1,2,4-Oxadiazole antimicrobials act synergistically with daptomycin and display rapid kill kinetics against MDR Enterococcus faecium. Carter GP; Harjani JR; Li L; Pitcher NP; Nong Y; Riley TV; Williamson DA; Stinear TP; Baell JB; Howden BP J Antimicrob Chemother; 2018 Jun; 73(6):1562-1569. PubMed ID: 29518208 [TBL] [Abstract][Full Text] [Related]
35. Phenotypic and genotypic characterization of vancomycin-resistant Enterococcus faecium clinical isolates from two hospitals in Mexico: First detection of VanB phenotype-vanA genotype. Bocanegra-Ibarias P; Flores-Treviño S; Camacho-Ortiz A; Morfin-Otero R; Villarreal-Treviño L; Llaca-Díaz J; Martínez-Landeros EA; Rodríguez-Noriega E; Calzada-Güereca A; Maldonado-Garza HJ; Garza-González E Enferm Infecc Microbiol Clin; 2016; 34(7):415-21. PubMed ID: 26589756 [TBL] [Abstract][Full Text] [Related]
36. Novel antibiotic regimens against Enterococcus faecium resistant to ampicillin, vancomycin, and gentamicin. Landman D; Mobarakai NK; Quale JM Antimicrob Agents Chemother; 1993 Sep; 37(9):1904-8. PubMed ID: 8239604 [TBL] [Abstract][Full Text] [Related]
37. Molecular characterization of vancomycin-resistant Enterococcus spp. clinical isolates recovered from hospitalized patients among several medical institutions in China. Sun H; Wang H; Xu Y; Jones RN; Costello AJ; Liu Y; Li G; Chen M; Mendes RE Diagn Microbiol Infect Dis; 2012 Dec; 74(4):399-403. PubMed ID: 23099304 [TBL] [Abstract][Full Text] [Related]
38. Daptomycin: A viable therapeutic option for vancomycin-resistant enterococcal urinary-tract infections in Indian medical settings? Mohan B; Garg S; Appannanavar SB; Taneja N Indian J Med Microbiol; 2016; 34(3):398-9. PubMed ID: 27514977 [No Abstract] [Full Text] [Related]
39. In-vitro synergistic activity of the combination of ampicillin and arbekacin against vancomycin-and high-level gentamicin-resistant Enterococcus faecium with the aph(2")-Id gene. Kak V; You I; Zervos MJ; Kariyama R; Kumon H; Chow JW Diagn Microbiol Infect Dis; 2000 Aug; 37(4):297-9. PubMed ID: 10974585 [TBL] [Abstract][Full Text] [Related]